封面
市场调查报告书
商品编码
1672793

全球基因重组技术市场按产品类型、应用、最终用户和地区划分

Recombinant Dna Technology Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 183 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球重组基因技术市场价值估计为 1,899.1 亿美元,预计到 2032 年将达到 3,656.2 亿美元,2025 年至 2032 年的复合年增长率为 9.8%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 1899.1亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 9.80% 2032 年价值预测 3656.2亿美元
数字。 2025 年基因工程技术市场占有率(%),依地区划分
重组 DNA 技术市场-IMG1

重组基因工程涉及将来自两个不同来源的 DNA 分子组合成一个分子,该分子可以指导其自身构建块和相关蛋白质的复製和组装。这个过程涉及透过使用限制酶、DNA连接酶和逆转录酶将两条不同的 DNA 链物理连接和交织在一起。最近的进展表明,重组基因技术是遗传学和生物技术领域的革命性进步,其应用范围广泛,包括药物开发、研究和农业。与传统萃取方法相比,该技术可以生产出更大量的人类蛋白质和药物。它也被用于开发目前无法治癒的疾病的新治疗方法以及提高农作物产量。由于各行业的需求不断增加,重组基因技术市场预计未来几年将大幅成长。

市场动态:

重组基因技术市场受到多种因素的推动,包括製药和生物技术行业研发活动的增加、慢性病盛行率的上升以及对基因工程和基因治疗的需求不断增长。此外,对经济实惠的医疗保健和治疗解决方案的需求,加上 DNA 分析和定序技术的技术进步,正在推动市场成长。然而,高成本和严格的临床试验规定可能会限制市场的成长。此外,围绕生殖系基因编辑的伦理问题可能会阻碍市场扩张。另一方面,新兴市场医疗支出的增加为主要企业提供了有利可图的机会。此外,随着基改作物在农业上的应用越来越广泛,预计未来几年将创造新的收益来源。

本研究的主要特点

  • 本报告对全球重组基因技术市场进行了详细分析,并以 2024 年为基准年,给出了预测期(2025-2032 年)的市场规模和復合年增长率。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 报告根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数,对全球重组基因技术市场的主要企业进行了概述。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球重组基因技术市场迎合了该行业的各种相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过用于分析全球基因改造技术市场的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 最新动态
  • 监管情景
  • 技术进步
  • 製造商收益
  • 收购和合作场景
  • 产品发布/核准
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第 4 章 全球基因改造技术市场:COVID-19 疫情的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 全球基因改造技术市场依产品类型划分(2020-2032 年)

  • 重组蛋白药物
  • 疫苗
  • 基因改造作物
  • 细胞和基因治疗
  • 基因编辑

6. 全球基因改造技术市场按应用划分(2020-2032 年)

  • 治疗
  • 农业
  • 研究
  • 其他的

7. 全球基因改造技术市场(按最终用户划分) (2020-2032)

  • 生技及製药公司
  • 诊断实验室
  • 学术和政府实验室
  • 其他的

8. 全球基因改造技术市场(按地区划分) (2020-2032)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Biogen, Inc.
    • Sanofi
    • Pfizer, Inc.
    • Amgen, Inc.
    • Merck &Co., Inc.
    • Profacgen
    • Monsanto Company
    • Genentech Inc.
    • Eli Lilly and Company
    • Janssen Pharmaceuticals Inc.
    • GSK plc.
    • Jiangsu Recbio Technology Co., Ltd.
    • New England Biolabs
    • GenScript
    • Lonza
    • ProteoGenix

第 10 章 分析师观点

  • 命运之轮
  • 分析师观点
  • Coherent Opportunity Map(COM)

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI893

Global Recombinant Dna Technology Market is estimated to be valued at USD 189.91 Bn in 2025 and is expected to reach USD 365.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 189.91 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.80% 2032 Value Projection: USD 365.62 Bn
Figure. Recombinant Dna Technology Market Share (%), By Region 2025
Recombinant Dna Technology Market - IMG1

Recombinant DNA technology is the joining together of DNA molecules from two different sources into one molecule that can replicate and direct the assembly of its own components or related proteins. This process involves physically combining and interweaving two different strands of DNA through the use of restriction enzymes, DNA ligases and reverse transcriptase. In recent years, recombinant DNA technology has proven to be a revolutionary advancement in the field of genetics and biotechnology with wide ranging applications in drug development, research, and agriculture. This technology allows for the production of human proteins and medicines in much larger quantities than traditional extraction methods. It is also being used to develop new treatments for currently incurable diseases and to enhance crop yields. With growing demand across industries, the recombinant DNA technology market is poised to grow significantly in the coming years.

Market Dynamics:

The recombinant DNA technology market is driven by several factors such as increasing R&D activities in pharmaceutical and biotech industries, rising prevalence of chronic diseases, growing demand for genetic engineering, and gene therapy. The demand for affordable healthcare and therapeutic solutions combined with technological advancements in DNA analysis and sequencing techniques are also fueling the market growth. However, the market growth can be restricted due to high costs associated with development and stringent regulations for clinical trials. Moreover, ethical issues regarding germline gene editing may hamper market expansion to some extent. On the flip side, rising healthcare expenditures in emerging nations offer lucrative opportunities for key players. In addition, the growing acceptance of genetically modified crops for agriculture applications is expected to create new revenue pockets in the forthcoming years.

Key Features of the Study:

  • This report provides an in-depth analysis of the global recombinant DNA technology market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global recombinant DNA technology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi , Pfizer, Inc., Amgen, Inc., Merck & Co., Inc., Profacgen, Monsanto Company, Genentech Inc., Eli Lilly and Company, Janssen Pharmaceuticals Inc., GSK plc., Jiangsu Recbio Technology Co., Ltd., New England Biolabs, GenScript, Lonza, and ProteoGenix.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global recombinant DNA technology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant DNA technology market.

Detailed Segmentation-

  • By Product Type:
    • Recombinant Protein Drugs
    • Vaccines
    • Genetically Modified Crops
    • Cell and Gene Therapy
    • Gene Editing
  • By Application:
    • Therapeutics
    • Agriculture
    • Research
    • Others
  • By End User:
    • Biotechnology and Pharmaceutical Company
    • Diagnostic Laboratories
    • Academic and Government Laboratories
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific, Inc.
    • Biogen, Inc.
    • Sanofi
    • Pfizer, Inc.
    • Amgen, Inc.
    • Merck & Co., Inc.
    • Profacgen
    • Monsanto Company
    • Genentech Inc.
    • Eli Lilly and Company
    • Janssen Pharmaceuticals Inc.
    • GSK plc.
    • Jiangsu Recbio Technology Co., Ltd.
    • New England Biolabs
    • GenScript
    • Lonza
    • ProteoGenix

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Regulatory Scenario
  • Technological Advancements
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Recombinant DNA Technology Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Recombinant DNA Technology Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Recombinant Protein Drugs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Vaccines
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Genetically Modified Crops
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cell and Gene Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gene Editing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Recombinant DNA Technology Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Therapeutics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Agriculture
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Recombinant DNA Technology Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Biotechnology and Pharmaceutical Company
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Laboratories
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and Government Laboratories
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Recombinant DNA Technology Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Biogen, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Pfizer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Amgen, Inc.
    • Merck & Co., Inc.
    • Profacgen
    • Monsanto Company
    • Genentech Inc.
    • Eli Lilly and Company
    • Janssen Pharmaceuticals Inc.
    • GSK plc.
    • Jiangsu Recbio Technology Co., Ltd.
    • New England Biolabs
    • GenScript
    • Lonza
    • ProteoGenix

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact

"